I85PREP
⌘ K
CMPP study materials
CMPP study resources

CMPP practice questions

One question at a time. Build your CMPP understanding.

First 50 of 200 questions. Each one lists the choices, the correct answer, and an explanation. The checker at the top of this page saves progress in this browser when it is available.

Continue in the practice tool above to load more questions, 50 at a time.

Question 1Medical publication strategy and planning

In medical publication planning, what is the primary purpose of a publication steering committee?

  1. To provide strategic oversight of the publication plan and resolve data-driven decisions independent of commercial influence Correct answer.
  2. To approve marketing collateral and promotional budgets for the brand team
  3. To negotiate journal open-access fees on behalf of the sponsor
  4. To recruit authors from competitor organizations

Explanation

A publication steering committee gives strategic direction and scientific oversight across the publication plan, and its decisions must remain independent of commercial and promotional interests. It is not a marketing approval body. Its role centers on scientific integrity, gap analysis, and governance of authorship and disclosure.

Question 2Medical publication strategy and planning

A publication plan is best described as which of the following?

  1. A fixed list of manuscripts submitted once at the start of a program
  2. A promotional calendar owned by the sales organization
  3. A living strategic document that maps planned publications to data availability and communication objectives over time Correct answer.
  4. A regulatory submission dossier for a single indication

Explanation

A publication plan is a living, iterative document that aligns planned publications with data maturity, communication objectives, and stakeholder needs, and it is revisited as data and the landscape evolve. It is not a one-time static list. It is also distinct from promotional planning and from regulatory dossiers.

Question 3Medical publication strategy and planning

Which element most directly supports the scientific gap analysis step of publication planning?

  1. A review of the sales force's quarterly call quotas
  2. A forecast of manufacturing capacity for the coming year
  3. An audit of the sponsor's travel and expense policy
  4. A landscape review of existing literature and congress data to identify unmet communication needs Correct answer.

Explanation

Gap analysis compares what is already published with what the program needs to communicate, so a structured review of the existing literature and congress presentations is central. It identifies where evidence is missing or where a message lacks support. Operational and financial audits do not inform scientific communication gaps.

Question 4Medical publication strategy and planning

What does the term 'publication deliverable' typically encompass in a publication plan?

  1. Only peer-reviewed journal articles
  2. Manuscripts, congress abstracts and posters, oral presentations, and plain-language summaries Correct answer.
  3. Only conference posters
  4. Only regulatory briefing documents

Explanation

Publication deliverables span the full range of scientific communications, including manuscripts, abstracts, posters, oral presentations, and increasingly plain-language or patient summaries. Limiting the term to one format misrepresents the breadth of the plan. Regulatory documents are a distinct category.

Question 5Medical publication strategy and planning

Why should a publication plan be developed with cross-functional input from medical affairs, biostatistics, and clinical development?

  1. To ensure planned publications reflect data maturity, analysis timelines, and clinical context accurately Correct answer.
  2. To guarantee that commercial targets determine which results are published
  3. To reduce the number of authors listed on each manuscript
  4. To avoid the need for any external journal peer review

Explanation

Cross-functional input ensures the plan is realistic and scientifically grounded, because biostatistics knows when analyses will be ready, clinical development knows the study context, and medical affairs understands the communication landscape. It is not a mechanism for commercial control of results. Nor does it bypass peer review.

Question 6Medical publication strategy and planning

Which document commonly defines authorship criteria and the process for resolving authorship disputes within a publication plan?

  1. The publication policy or standard operating procedure governing publications Correct answer.
  2. The pharmacovigilance signal management plan
  3. The clinical study report appendix
  4. The brand's promotional review committee charter

Explanation

A publication policy or SOP sets out authorship criteria, dispute resolution, and disclosure requirements that govern all planned publications. It provides the rules that authors and teams follow. Promotional charters, clinical report appendices, and safety plans do not govern authorship.

Question 7Medical publication strategy and planning

What is the main role of a publication manager within a medical publications team?

  1. Serving as the sole statistical author of every manuscript
  2. Coordinating development, review, and submission of planned publications while tracking timelines and compliance Correct answer.
  3. Approving the brand's advertising spend
  4. Conducting regulatory inspections of clinical sites

Explanation

A publication manager coordinates the operational delivery of the publication plan, tracking timelines, facilitating internal review, and ensuring compliance with policy and disclosure requirements. The role is coordinative rather than statistical or commercial. It does not involve site inspections.

Question 8Medical publication strategy and planning

Which of the following best reflects the principle of transparency in medical publication planning?

  1. Publishing only results that favor the product
  2. Sharing planned publications exclusively with the sales team
  3. Delaying disclosure until after a promotional campaign launches
  4. Prospectively disclosing planned studies and making results publicly accessible regardless of outcome Correct answer.

Explanation

Transparency means prospective registration and disclosure of studies and timely public access to results, whether positive or negative. It is a core ethical expectation for publication planning. Selective or delayed disclosure tied to promotion undermines that principle.

Question 9Medical publication strategy and planning

A sponsor wants to add a manuscript to the publication plan before the primary endpoint analysis is locked. What is the most appropriate planning response?

  1. Commit a submission date and begin drafting results immediately
  2. Assign authorship to the commercial team to speed up drafting
  3. Record the planned manuscript as contingent on data availability and set a provisional timeline pending analysis lock Correct answer.
  4. Remove the manuscript because planning before lock is prohibited

Explanation

Planned publications should be tied to realistic data maturity, so a manuscript dependent on an unlocked analysis is best recorded as contingent with a provisional timeline. This preserves plan integrity while allowing tracking. Committing to dates or drafting results before lock risks inaccuracy, and commercial authorship is inappropriate.

Question 10Medical publication strategy and planning

During annual plan review, a team finds three planned congress abstracts overlap heavily with one another. What is the best strategic action?

  1. Convert the abstracts into promotional brochures
  2. Consolidate or differentiate the abstracts so each communicates a distinct, non-duplicative data message Correct answer.
  3. Cancel all congress activity for the year
  4. Submit all three unchanged to maximize visibility

Explanation

Redundant abstracts waste resources and can create duplicate-publication concerns, so the plan should be revised so each abstract conveys a distinct message or the outputs are consolidated. Submitting duplicates unchanged risks ethics issues. Cancelling all activity or shifting to promotion does not serve scientific communication.

Question 11Medical publication strategy and planning

A publication plan includes a health economics and outcomes research manuscript. Which planning consideration is most specific to this deliverable?

  1. Removing all disclosure statements to protect proprietary methods
  2. Aligning the economic model assumptions and payer-relevant endpoints with the target journal's audience Correct answer.
  3. Ensuring the manuscript is authored only by sales representatives
  4. Scheduling submission to coincide with a price increase announcement

Explanation

HEOR manuscripts depend on model assumptions and payer-relevant outcomes, so the plan should align these with the chosen journal's readership and methodological expectations. Authorship must follow criteria, and disclosure cannot be removed. Tying submission to pricing announcements is commercially driven and inappropriate.

Question 12Medical publication strategy and planning

Which approach best integrates patient-facing plain-language summaries into a publication plan?

  1. Delegating them entirely to the sales force without medical review
  2. Drafting them only after all manuscripts are published, without review
  3. Planning them alongside each primary manuscript with a defined review and plain-language writing process Correct answer.
  4. Omitting them because lay audiences are outside publication strategy

Explanation

Plain-language summaries are increasingly expected, so they should be planned in parallel with the primary manuscript and follow a defined plain-language writing and medical review process. Delayed, unreviewed, or commercially delegated drafting risks inaccuracy and loss of trust. Lay communication is a legitimate part of publication strategy.

Question 13Medical publication strategy and planning

When prioritizing which planned publications to resource first, which criterion is most aligned with publication strategy?

  1. The number of authors willing to travel to congresses
  2. The seniority of the sponsor's commercial leadership
  3. The strength of the data and its relevance to an identified communication gap Correct answer.
  4. The size of the journal's advertising rates

Explanation

Prioritization should reflect scientific value, meaning data strength and the size of the communication gap the publication addresses. Commercial seniority, travel willingness, and advertising rates are not valid scientific prioritization criteria. They would distort the plan toward non-scientific considerations.

Question 14Medical publication strategy and planning

A team plans to submit the same dataset to two journals simultaneously to increase the chance of acceptance. What is the correct publication planning guidance?

  1. Submit to one journal at a time and only resubmit elsewhere after a decision or withdrawal Correct answer.
  2. Submit simultaneously only if one journal is open access
  3. Submit simultaneously but list different authors on each version
  4. Proceed with simultaneous submission because journals rarely check

Explanation

Simultaneous submission of the same work to multiple journals is a breach of publication ethics, so the plan should sequence submissions one journal at a time. Resubmission follows a decision or withdrawal. Altering authors or choosing open access does not legitimize duplicate submission.

Question 15Medical publication strategy and planning

How should a publication plan handle a planned manuscript whose target journal has a very long turnaround time?

  1. Submit to a predatory journal to shorten the process
  2. Assume immediate acceptance and schedule dependent activities accordingly
  3. Abandon the manuscript because of the delay
  4. Build the expected review timeline into the plan and identify contingency venues or formats Correct answer.

Explanation

Realistic planning accounts for journal turnaround and includes contingencies, such as alternative venues or interim congress presentations, so dependent activities are not derailed. Assuming immediate acceptance is unrealistic. Abandoning the work or using a predatory journal undermines scientific quality.

Question 16Medical publication strategy and planning

Which factor most strongly justifies including a secondary endpoint manuscript in the publication plan?

  1. The endpoint addresses a clinically meaningful question not covered by the primary publication Correct answer.
  2. The endpoint data are easy to analyze quickly
  3. The endpoint produced a statistically significant result regardless of clinical relevance
  4. The commercial team wants additional promotional talking points

Explanation

Secondary endpoint publications are justified when they answer a clinically meaningful question that the primary publication does not address. Statistical significance alone, without clinical relevance, is insufficient justification. Commercial talking points and ease of analysis are not scientific rationales.

Question 17Medical publication strategy and planning

A publication plan review reveals that a planned review article duplicates an already published systematic review. What is the most defensible strategic decision?

  1. Reframe the planned article to add new value, such as an updated analysis or a different perspective Correct answer.
  2. Cancel all review articles permanently
  3. Convert it into a promotional white paper
  4. Publish the duplicate anyway to increase citation counts

Explanation

A planned review should contribute something new, so reframing it to provide an updated analysis or distinct perspective preserves value and avoids duplication. Publishing a duplicate adds little and risks ethics concerns. Permanently cancelling reviews or converting to promotion does not serve the strategy.

Question 18Medical publication strategy and planning

Why is early engagement with target journals' author guidelines important during publication planning?

  1. It allows the sponsor to influence peer reviewers
  2. It removes the need for internal medical review
  3. It informs format, word limits, and disclosure requirements that shape drafting and timelines Correct answer.
  4. It guarantees acceptance of the manuscript

Explanation

Author guidelines define formatting, length, reporting standards, and disclosure requirements, so early engagement lets teams plan drafting effort and timelines realistically. It does not guarantee acceptance or permit reviewer influence. Internal review remains necessary regardless.

Question 19Medical publication strategy and planning

A publication plan must accommodate a negative primary study result. Which planning principle applies?

  1. Suppress the result and publish only positive secondary analyses
  2. Plan to publish the result transparently because the study question and data remain scientifically valuable Correct answer.
  3. Publish the negative result only in a promotional context
  4. Delay publication indefinitely until a positive result emerges

Explanation

Negative or null results are scientifically valuable and must be disclosed transparently to avoid publication bias. Suppressing them or waiting for favorable data violates disclosure principles. Restricting them to promotional use is inappropriate.

Question 20Medical publication strategy and planning

In publication planning, what distinguishes a 'core data' publication from a 'supportive' publication?

  1. Core data publications are always open access, while supportive ones are subscription only
  2. Core data publications appear only in congresses, while supportive ones appear only in journals
  3. Core data publications report primary efficacy or safety findings, while supportive publications provide context such as reviews or real-world evidence Correct answer.
  4. Core data publications are written by commercial staff, while supportive ones are written by investigators

Explanation

Core data publications present the primary efficacy or safety evidence from pivotal studies, whereas supportive publications add context through reviews, real-world evidence, or methodological work. Access model, authorship, and venue do not define the distinction. The classification rests on the type of evidence conveyed.

Question 21Medical publication strategy and planning

A sponsor's publication plan proposes a manuscript authored solely by a medical writing agency employee with no investigator involvement. What is the primary concern?

  1. The manuscript will automatically be rejected by every journal
  2. The investigator team will lose access to the data
  3. The agency employee will demand higher fees
  4. Authorship criteria may not be met, and professional medical writing support must be disclosed with qualifying authors Correct answer.

Explanation

Authorship requires substantive intellectual contribution and accountability, which a sole agency author may not satisfy, and professional medical writing support must be acknowledged and disclosed. Fee concerns, universal rejection, and data access are not the central ethical issue. The core problem is authorship integrity and transparency.

Question 22Medical publication strategy and planning

An integrated publication plan spans multiple regions with different disclosure regulations. What is the most robust planning approach?

  1. Delegate all disclosure decisions to local sales teams
  2. Apply each region's minimum requirements separately with no common baseline
  3. Adopt the strictest applicable disclosure standard as the baseline across all regions Correct answer.
  4. Exclude regions with strict requirements from the plan

Explanation

Using the strictest applicable disclosure standard as a global baseline ensures compliance everywhere and simplifies governance, while local requirements can be layered on top. Applying only regional minimums creates inconsistency and compliance risk. Excluding regions or delegating to sales undermines the plan.

Question 23Medical publication strategy and planning

A publication steering committee is asked to approve a manuscript whose conclusions overstate the data. What is the committee's most appropriate action?

  1. Require the conclusions to be revised to match the data before approval Correct answer.
  2. Refer the manuscript to the sales organization for a final decision
  3. Approve it because the committee's role is only logistical
  4. Approve it conditionally on the commercial team's agreement

Explanation

Scientific oversight requires that conclusions be supported by the data, so the committee should require revision before approval. Approving overstated conclusions, deferring to commercial agreement, or handing the decision to sales all compromise scientific integrity. The committee's mandate is precisely to safeguard accuracy.

Question 24Medical publication strategy and planning

Which scenario best demonstrates a conflict between publication planning and the ICMJE principle of editorial independence?

  1. A sponsor contractually requires a journal to publish a manuscript without peer review Correct answer.
  2. A sponsor provides data to investigators who draft the manuscript independently
  3. A sponsor funds medical writing support that is disclosed in the manuscript
  4. A sponsor registers a trial prospectively on a public registry

Explanation

Editorial independence means journals control peer review and publication decisions, so a sponsor contractually requiring publication without peer review directly violates this principle. Disclosed writing support, investigator-led drafting, and prospective registration are all consistent with ethical practice. They do not compromise editorial independence.

Question 25Medical publication strategy and planning

A publication plan is being built for a first-in-class therapy with limited existing literature. Which planning adjustment is most appropriate?

  1. Focus solely on promotional materials to create awareness
  2. Wait until competitors publish before planning any output
  3. Reduce all publications because little literature exists
  4. Emphasize educational and mechanism-focused outputs to build the evidence narrative alongside pivotal results Correct answer.

Explanation

When existing literature is sparse, the plan should build the scientific narrative through educational and mechanism-focused publications that contextualize the pivotal data. Reducing output, shifting to promotion, or waiting for competitors fails to establish the evidence base. The gap itself signals communication opportunity.

Question 26Medical publication strategy and planning

In medical publication strategy, what is the primary purpose of a gap analysis?

  1. To determine the exact number of figures each manuscript should contain
  2. To rank journals by their impact factor for submission targeting
  3. To estimate the cost of medical writing vendors for the coming year
  4. To identify what is already published and where evidence or communication gaps remain Correct answer.

Explanation

A gap analysis systematically maps the existing literature and disclosure landscape against the evidence a program needs to communicate, revealing where new publications or formats are required. It is a strategic planning step, not a budgeting, journal-ranking, or formatting exercise.

Question 27Medical publication strategy and planning

Which element is most characteristic of a publication plan's 'strategic framework' section?

  1. A list of every investigator who contributed data
  2. A detailed statistical analysis plan for the pivotal trial
  3. A copy of the target journal's reference style guide
  4. A statement of publication objectives tied to the product's evidence and communication needs Correct answer.

Explanation

The strategic framework articulates why the publication program exists, linking objectives to the evidence base and stakeholder communication needs. Investigator lists, statistical plans, and journal style guides are operational or manuscript-level documents, not strategy.

Question 28Medical publication strategy and planning

What is the main function of a publication plan's timeline or milestone map?

  1. To guarantee that every planned manuscript will be accepted by its target journal
  2. To sequence data availability, manuscript development, and submission targets against key events Correct answer.
  3. To replace the need for a separate publication steering committee
  4. To document the exact wording of every abstract before data lock

Explanation

A milestone map aligns publication activities with data readouts, congress deadlines, and regulatory events so that resources and submissions are sequenced realistically. It cannot guarantee acceptance or substitute for governance, and it does not fix abstract wording in advance.

Question 29Medical publication strategy and planning

Which audience is most directly served by a publication plan's congress abstract and poster track?

  1. Journal copyeditors preparing accepted manuscripts for typesetting
  2. Health technology assessment bodies deciding on reimbursement
  3. Clinical practitioners and researchers attending specialty meetings Correct answer.
  4. Regulatory reviewers assessing the marketing application

Explanation

Congress abstracts and posters are designed for rapid dissemination to the specialist community attending scientific meetings. Regulatory reviewers, HTA bodies, and journal copyeditors use different documents and channels.

Question 30Medical publication strategy and planning

What does 'publication steering committee' governance typically provide to a medical publication program?

  1. Final approval of the product's regulatory label
  2. Day-to-day line management of medical writers
  3. Direct negotiation of journal subscription fees
  4. Oversight of publication strategy, prioritization, and adherence to publication policies Correct answer.

Explanation

A publication steering committee oversees strategy, prioritization, and policy compliance across the publication program. It does not manage writers operationally, approve regulatory labels, or handle journal subscriptions.

Question 31Medical publication strategy and planning

Which document typically records the agreed order of authors and their specific contributions for a planned manuscript?

  1. The trial's informed consent form
  2. The manuscript's authorship agreement or contributor statement Correct answer.
  3. The target journal's instructions to authors
  4. The publication plan's executive summary

Explanation

Author order and specific contributions are documented in an authorship agreement or contributor statement tied to the individual manuscript. Executive summaries, journal instructions, and consent forms serve different purposes.

Question 32Medical publication strategy and planning

Why is it important to identify the primary endpoint manuscript early in publication planning?

  1. It usually carries the core evidence and anchors the timing and messaging of supportive publications Correct answer.
  2. It determines the color scheme for all program publications
  3. It must always be published before any congress presentation is given
  4. It is the only manuscript that requires ethics committee approval

Explanation

The primary endpoint manuscript typically presents the pivotal result and therefore shapes the sequence and messaging of secondary and supportive publications. It does not dictate visual design, is not the sole ethics item, and does not always precede every congress activity.

Question 33Medical publication strategy and planning

In publication planning, what is the purpose of a 'publication snapshot' or landscape review?

  1. To provide a one-page summary of the target journal's impact factor
  2. To replace the need for ongoing literature monitoring
  3. To capture the current state of published and planned disclosures for a therapy area at a point in time Correct answer.
  4. To photograph the study team for the manuscript acknowledgments

Explanation

A publication snapshot records what has been published or is planned at a given moment, supporting gap identification and prioritization. It is a strategic record, not a literal photograph, journal metric, or substitute for continuous monitoring.

Question 34Medical publication strategy and planning

A publication team learns that a competitor has just published a trial with a similar mechanism. How should the team most appropriately respond in the publication plan?

  1. Ignore the competitor publication because it does not affect the team's own data
  2. Reassess the evidence landscape and adjust messaging, targeting, or timing where justified Correct answer.
  3. Immediately submit an unplanned manuscript before the data are locked
  4. Withdraw all planned publications to avoid overlap

Explanation

New competitor evidence changes the communication context and may warrant revising positioning, target journals, or sequencing. Ignoring it, rushing unlocked data, or canceling the program are disproportionate responses.

Question 35Medical publication strategy and planning

A publication plan lists a secondary analysis manuscript but no owner or draft timeline. What is the most appropriate planning action?

  1. Merge it into the primary manuscript regardless of journal limits
  2. Assign a responsible author or team and set development milestones with dependencies Correct answer.
  3. Submit the manuscript immediately without a draft
  4. Remove the manuscript from the plan until someone volunteers

Explanation

Every planned publication needs an accountable owner and realistic milestones so that it can be resourced and tracked. Removing it, submitting without a draft, or merging regardless of journal limits creates avoidable risk.

Question 36Medical publication strategy and planning

A program has strong phase 2 data and a phase 3 trial still enrolling. Which planning approach best balances early communication with data integrity?

  1. Delay all publications until phase 3 is fully published
  2. Plan phase 2 publications now while scheduling phase 3 manuscripts contingent on final analysis Correct answer.
  3. Present phase 3 interim results without disclosing their interim status
  4. Publish phase 3 conclusions before the trial completes

Explanation

Phase 2 evidence can be responsibly communicated while phase 3 manuscripts are planned with dependencies on final analysis and disclosure requirements. Publishing premature conclusions, delaying everything, or hiding interim status undermines integrity.

Question 37Medical publication strategy and planning

A publication plan includes a plain-language summary for trial participants. Which planning consideration is most specific to this deliverable?

  1. Assigning a journal manuscript ID to the summary
  2. Ensuring readability and return of results to participants in accessible language Correct answer.
  3. Formatting the summary to journal reference style
  4. Selecting an impact factor threshold for the summary

Explanation

Plain-language summaries for participants must be understandable and accessible, fulfilling return-of-results expectations. Impact factors, manuscript IDs, and reference styles apply to journal articles, not participant summaries.

Question 38Medical publication strategy and planning

A publication plan proposes a narrative review authored by a sponsor employee only. What is the most appropriate planning response?

  1. Proceed because single-author reviews are always acceptable
  2. Cancel all review articles in the plan
  3. Recruit independent external expertise and ensure the review adds a clearly defined perspective Correct answer.
  4. Convert the review into a primary research article

Explanation

Reviews gain credibility from independent expertise and a clearly defined contribution beyond existing literature. Single-author sponsor reviews raise independence concerns, canceling all reviews is excessive, and converting a review into primary research misrepresents its nature.

Question 39Medical publication strategy and planning

A publication team is planning abstracts for three congresses with overlapping deadlines. Which planning decision best manages the risk of duplicate disclosure?

  1. Wait until after all congresses to decide on any abstract
  2. Submit identical abstracts to all three without coordination
  3. Coordinate content and timing, and check each congress's prior-presentation policy Correct answer.
  4. Submit only to the congress with the highest attendance

Explanation

Coordinating content and checking each congress's policy on prior presentation prevents duplicate disclosure and policy violations. Submitting identical abstracts, choosing by attendance alone, or delaying all decisions does not address the risk.

Question 40Medical publication strategy and planning

A publication plan must support both a global manuscript and local-language adaptations for several countries. Which planning element is most critical?

  1. A single global timeline that ignores local regulatory review cycles
  2. A localization workflow with translation, local review, and country-specific disclosure checks Correct answer.
  3. A rule that local adaptations must not cite the global manuscript
  4. A requirement that all countries use the same journal

Explanation

Local-language adaptations require translation quality control, local expert review, and compliance with country-specific disclosure rules. A single global timeline, forced journal choice, or prohibition on citing the global manuscript would undermine the adaptation.

Question 41Medical publication strategy and planning

A planned manuscript relies on data from a study whose database lock has slipped by two quarters. What is the most appropriate planning adjustment?

  1. Drop the manuscript permanently from the plan
  2. Submit the manuscript with preliminary data labeled as final
  3. Keep the original submission date and draft with placeholder results
  4. Re-sequence dependent publications and communicate the revised timeline to stakeholders Correct answer.

Explanation

When data availability shifts, dependent publications should be re-sequenced and the revised timeline communicated transparently. Drafting with placeholders, dropping the manuscript permanently, or mislabeling preliminary data are inappropriate.

Question 42Medical publication strategy and planning

A publication plan includes a health economic model manuscript. Which planning consideration is most specific to this publication type?

  1. Ensuring the model structure, inputs, and assumptions are transparent and reproducible Correct answer.
  2. Confirming the manuscript contains no tables
  3. Avoiding any description of the model's limitations
  4. Selecting a journal based solely on its acceptance rate

Explanation

Health economic model manuscripts must disclose structure, inputs, and assumptions so that readers and HTA reviewers can assess reproducibility. Journal acceptance rate alone, a no-tables rule, or omitting limitations would undermine credibility.

Question 43Medical publication strategy and planning

A publication plan is being built for a rare disease with very few eligible trial sites. Which planning adjustment is most appropriate?

  1. Plan for fewer but higher-value publications and consider case reports or registry analyses Correct answer.
  2. Assume the same publication volume as a common disease program
  3. Submit every analysis to the highest-impact journal regardless of fit
  4. Avoid publishing because the evidence base is small

Explanation

Rare disease programs typically support fewer publications, so planners should prioritize high-value outputs and consider alternative formats such as case reports or registry analyses. Assuming common-disease volume, avoiding publication, or ignoring journal fit are poor strategies.

Question 44Medical publication strategy and planning

A publication steering committee is reviewing a plan that includes a manuscript on an unvalidated biomarker. Which planning decision is most defensible?

  1. Remove all mention of the biomarker from the plan
  2. Plan the manuscript as exploratory and clearly label the biomarker's validation status Correct answer.
  3. Present the biomarker as validated to strengthen the manuscript
  4. Delay the manuscript until the biomarker is approved as a companion diagnostic

Explanation

Exploratory biomarker findings can be published if their validation status is clearly disclosed and conclusions are appropriately bounded. Overstating validation, removing the topic entirely, or waiting for diagnostic approval are not necessary or appropriate.

Question 45Medical publication strategy and planning

Two planned manuscripts draw on the same trial dataset but address different endpoints. What planning approach best supports both submissions?

  1. Ensure each manuscript has a distinct research question and cross-reference the companion publication Correct answer.
  2. Combine both into one manuscript regardless of journal length limits
  3. Submit both to the same journal on the same day without disclosure
  4. Publish only the manuscript with the more favorable result

Explanation

Distinct research questions and cross-referencing allow companion manuscripts to be published transparently without duplicate publication concerns. Simultaneous undisclosed submission, forced combination, or selective publication of favorable results is inappropriate.

Question 46Medical publication strategy and planning

A publication plan is reviewed against the requirement that trial results be posted in a public registry. Which planning element should explicitly link to this obligation?

  1. The journal's impact factor
  2. The number of figures in the primary manuscript
  3. The manuscript reference list
  4. The results-disclosure milestone and responsible owner Correct answer.

Explanation

Results posting is a disclosure obligation with deadlines, so the plan should assign a milestone and an accountable owner. Reference lists, impact factors, and figure counts do not address registry disclosure.

Question 47Medical publication strategy and planning

A publication plan is being evaluated for alignment with the principle that trial results should be published regardless of outcome. Which planning feature best demonstrates this alignment?

  1. A policy of waiting indefinitely for favorable additional analyses
  2. A rule that only statistically significant results will be submitted
  3. A contingency plan that commits to publishing negative or null results in a suitable venue Correct answer.
  4. A requirement that all manuscripts be authored by the sponsor

Explanation

Committing in advance to publish negative or null results, with an identified suitable venue, demonstrates alignment with outcome-independent publication. Restricting to significant results, indefinite delay, or sponsor-only authorship does not.

Question 48Medical publication strategy and planning

A publication plan proposes a 'data on file' statement as the sole support for a key efficacy claim in a peer-reviewed manuscript. What is the most appropriate planning judgment?

  1. Replace the claim with a marketing slogan
  2. Reject it as sole support and plan to present analyzable data or a clear citation Correct answer.
  3. Accept it because data on file is always sufficient for peer review
  4. Remove the efficacy claim but keep the data on file statement

Explanation

Peer-reviewed manuscripts require verifiable support, so a data-on-file statement cannot stand alone for a key efficacy claim. Accepting it, substituting marketing language, or keeping an unsupported statement would fail editorial and integrity standards.

Question 49Medical publication strategy and planning

A publication plan is asked to accelerate a manuscript to meet a product launch date. Which action best preserves scientific integrity while addressing the business need?

  1. Prioritize the manuscript within the existing review process and communicate realistic timing to stakeholders Correct answer.
  2. Add promotional claims to make the manuscript more launch-relevant
  3. Bypass internal medical and regulatory review
  4. Submit before the analysis is complete to meet the date

Explanation

Acceleration should occur through prioritization and transparent communication, not by compromising analysis, review, or content standards. Submitting incomplete work, bypassing review, or adding promotional claims would violate integrity requirements.

Question 50Medical publication strategy and planning

A publication plan includes a manuscript analyzing real-world evidence from a registry with potential immortal time bias. Which planning response is most appropriate?

  1. Exclude the registry analysis from the plan entirely
  2. Present the result as equivalent to randomized evidence
  3. Proceed without mentioning the bias because real-world evidence is inherently valid
  4. Plan explicit bias assessment, sensitivity analyses, and transparent limitation reporting Correct answer.

Explanation

Registry analyses with known biases should include explicit bias assessment, sensitivity analyses, and transparent limitations so readers can judge the findings. Ignoring bias, excluding the analysis, or equating it with randomized evidence misrepresents the data.